OA08506A - Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive. - Google Patents

Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive.

Info

Publication number
OA08506A
OA08506A OA59095A OA59095A OA08506A OA 08506 A OA08506 A OA 08506A OA 59095 A OA59095 A OA 59095A OA 59095 A OA59095 A OA 59095A OA 08506 A OA08506 A OA 08506A
Authority
OA
OAPI
Prior art keywords
compounds
prophylaxis
treatment
disorders
agents containing
Prior art date
Application number
OA59095A
Other languages
English (en)
French (fr)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of OA08506A publication Critical patent/OA08506A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
OA59095A 1986-03-27 1987-03-27 Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive. OA08506A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863610391 DE3610391A1 (de) 1986-03-27 1986-03-27 Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen

Publications (1)

Publication Number Publication Date
OA08506A true OA08506A (fr) 1988-07-29

Family

ID=6297417

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59095A OA08506A (fr) 1986-03-27 1987-03-27 Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive.

Country Status (25)

Country Link
EP (1) EP0243645B1 (sv)
JP (1) JPS62240698A (sv)
KR (1) KR870008841A (sv)
CN (1) CN1031267C (sv)
AT (1) ATE102954T1 (sv)
AU (1) AU621278B2 (sv)
CA (1) CA1341064C (sv)
CS (2) CS212687A3 (sv)
DD (1) DD280765A5 (sv)
DE (2) DE3610391A1 (sv)
DK (1) DK172221B1 (sv)
EG (1) EG18175A (sv)
ES (1) ES2061447T3 (sv)
FI (1) FI91876C (sv)
HU (2) HU202118B (sv)
IE (1) IE62456B1 (sv)
MA (1) MA20919A1 (sv)
NO (1) NO178546C (sv)
NZ (1) NZ219764A (sv)
OA (1) OA08506A (sv)
PH (1) PH27210A (sv)
PT (1) PT84564B (sv)
RU (1) RU1836335C (sv)
TN (1) TNSN87045A1 (sv)
ZA (1) ZA872230B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
AU612137B2 (en) * 1987-04-27 1991-07-04 E.R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing an ace inhibitor
DE3731085A1 (de) * 1987-09-16 1989-04-06 Hoechst Ag Neue aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE3801587A1 (de) * 1988-01-21 1989-08-03 Hoechst Ag Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0331609A3 (de) * 1988-01-27 1992-07-01 Hoechst Aktiengesellschaft Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung
DE3803225A1 (de) * 1988-02-04 1989-08-17 Hoechst Ag Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
US5037821A (en) * 1988-06-01 1991-08-06 E. R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor
US5093129A (en) * 1989-01-30 1992-03-03 E. R. Squibb & Sons, Inc. Method for treating addiction to a drug of abuse employing an ace inhibitor
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
AU2002245692A1 (en) * 2001-03-15 2002-10-03 David Pharmaceuticals Methods for restoring cognitive function following systemic stress

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050800B2 (en) * 1980-10-23 1995-06-07 Schering Corporation Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
DE3300774A1 (de) * 1983-01-12 1984-07-12 Hoechst Ag, 6230 Frankfurt Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung

Also Published As

Publication number Publication date
FI871304A0 (sv) 1987-03-25
DE3610391A1 (de) 1987-10-08
EP0243645A3 (en) 1990-01-24
KR870008841A (ko) 1987-10-21
DK172221B1 (da) 1998-01-12
CS276179B6 (en) 1992-04-15
CN87102304A (zh) 1987-12-30
FI871304A (sv) 1987-09-28
EP0243645A2 (de) 1987-11-04
IE870784L (en) 1987-09-27
ES2061447T3 (es) 1994-12-16
PT84564B (pt) 1989-11-10
TNSN87045A1 (fr) 1990-01-01
NZ219764A (en) 1990-11-27
DE3789330D1 (de) 1994-04-21
CN1031267C (zh) 1996-03-13
EP0243645B1 (de) 1994-03-16
HU203117B (en) 1991-05-28
FI91876B (sv) 1994-05-13
NO178546C (no) 1996-04-17
AU7064987A (en) 1987-10-01
CS276385B6 (en) 1992-05-13
ATE102954T1 (de) 1994-04-15
PT84564A (de) 1987-04-01
CS651989A3 (en) 1992-05-13
DK153587A (da) 1987-09-28
DD280765A5 (de) 1990-07-18
NO871282D0 (no) 1987-03-26
HU202118B (en) 1991-02-28
HUT46046A (en) 1988-09-28
NO871282L (no) 1987-09-28
DK153587D0 (da) 1987-03-26
EG18175A (en) 1994-07-30
HU896609D0 (en) 1990-02-28
FI91876C (sv) 1994-08-25
ZA872230B (en) 1987-09-21
PH27210A (en) 1993-05-04
CA1341064C (en) 2000-08-01
AU621278B2 (en) 1992-03-12
IE62456B1 (en) 1995-02-08
CS212687A3 (en) 1992-04-15
MA20919A1 (fr) 1987-10-01
NO178546B (no) 1996-01-08
JPS62240698A (ja) 1987-10-21
RU1836335C (ru) 1993-08-23

Similar Documents

Publication Publication Date Title
OA08506A (fr) Composés ayant un effet nootrope, agents contenant ces composés, et leur utilisation dans le traitement et la prophylaxie des troubles de la fonction cognitive.
FR2615394B1 (fr) Utilisation de certains 17-cetosteroides, eventuellement avec un immunomodulateur et/ou un agent antiviral, pour fabriquer un medicament pour le traitement et la prevention des infections retrovirales
IL89031A0 (en) Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
FR2541115B1 (fr) Medicament renfermant un peptide en tant que principe actif pour le traitement des affections ulcereuses
FR2430408A1 (fr) Phenethanolamines optiquement actives et leur utilisation therapeutique
EP0261595A3 (en) Pharmaceutical composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-didehydrocytidine) for treating patients infected with retrovirus
DE69330150D1 (de) Pharmazeutische Zusammensetzungen zur transdermalen Verabreichung von Melatonin und/oder seine Analoge
FR2398067A1 (fr) Nouvelles 4-pyrones substituees en positions 2, 3 et 6 et medicament les contenant
ES8504810A1 (es) Procedimiento de preparar compuestos tiopiranopirimidinicos farmacologicamente activos.
EP0999204A4 (en) CONNECTIONS TO PROMOTE NEURON DIFFERENTIATION
DE69327207D1 (de) Tryptamine zur Behandlung von Störungen der circadianen Rhythmik
FR2575158B1 (fr) Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
ATE122889T1 (de) Verwendung von mizoribin zur behandlung oder vorbeugung der multiplen sklerose.
EP0228034A3 (en) Arginine and agmatine derivatives for treating protozoal infections
RO95371B1 (ro) Medicament pentru tratamentul unor afectiuni alergice cronice
ZA89574B (en) Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system